Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2014
04/03/2014WO2014049300A1 Topical use of laropiprant for the treatment of rosacea
04/03/2014WO2014049299A1 Combination of laropiprant and brimonidine for the treatment of rosacea
04/03/2014WO2014049298A1 Combination of laropiprant and ivermectin for the treatment of rosacea
04/03/2014WO2014049297A1 Combination of laropiprant and oxymetazoline for the treatment of rosacea
04/03/2014WO2014049296A1 Combination of laropiprant and metronidazole for the treatment of rosacea
04/03/2014WO2014049295A1 Combination of laropiprant and doxycycline for the treatment of rosacea
04/03/2014WO2014049153A1 Antagonists of the 5-ht2b receptor for use in the prevention or treatment of spasticity
04/03/2014WO2014049152A1 Methods and pharmaceutical compositions for the treatment of cardiovascular fibrosis
04/03/2014WO2014049140A1 Improvements in or relating to oromucosal apomorphine compositions
04/03/2014WO2014049133A1 New positive allosteric modulators of nicotinic acetylcholine receptor
04/03/2014WO2014049112A1 Liquid concentrated vitamin e compositions
04/03/2014WO2014049107A1 Compounds for use in the treatment of mycobacterial infections
04/03/2014WO2014049079A1 Novel rig-i ligands and methods for producing them
04/03/2014WO2014049071A1 Modulators of androgen synthesis
04/03/2014WO2014049063A1 Formulations involving solvent/detergent-treated plasma (s/d plasma) and uses thereof
04/03/2014WO2014049047A1 Substituted sulfonamide compounds
04/03/2014WO2014049044A1 Methods and pharmaceutical compositions for the treatment of ulcerative colitis
04/03/2014WO2014048998A1 5-fluoruoracil derivatives
04/03/2014WO2014048953A1 Therapeutic use of hydrogen molecules
04/03/2014WO2014048945A1 Bet protein-inhibiting 5-aryl triazole azepines
04/03/2014WO2014048939A1 Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
04/03/2014WO2014048921A1 Combinations and uses thereof
04/03/2014WO2014048894A1 Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperfoliferative disorders
04/03/2014WO2014048888A1 Dihydroferulic acid and/or dihydrocaffeic acid for use in the treatment of metabolic diseases
04/03/2014WO2014048881A1 Combination of regorafenib and acetylsalicylic acid for treating cancer
04/03/2014WO2014048878A1 Phenyl- or pyridyl- pyrrolo[2,3b]pyrazine derivatives useful in the treatment or prevention of proliferative disorders or dysplasia
04/03/2014WO2014048869A1 Substituted indazol-pyrrolopyrimidines useful in the treatment of hyperproliferative diseases
04/03/2014WO2014048865A1 New bicyclic derivatives
04/03/2014WO2014048836A1 Stabilized aqueous compositions of neuromuscular blocking agents
04/03/2014WO2014048788A1 Methods for producing a population of pancreatic beta-cells
04/03/2014WO2014048783A1 A storage-stable dust-free homogeneous particulate formulation comprising at least one water-soluble vitamin e-derivative and at least one hydrophilic polymer
04/03/2014WO2014048782A1 A storage-stable dust-free homogeneous particulate formulation comprising at least one water-soluble vitamin e-derivative and at least one hydrophilic polymer
04/03/2014WO2014048584A1 Composition containing lysine as a nutritional supplement or treatment in the case of herpes
04/03/2014WO2014048564A1 "novel cross-linkers for hydrogels, hydrogels including these cross-linkers and applications thereof"
04/03/2014WO2014048547A1 Alpha hydroxy amides
04/03/2014WO2014048532A1 Quinazolinone derivatives as parp inhibitors
04/03/2014WO2014048511A1 Metadoxine for use in the treatment of liver diseases, and metadoxine extended release formulations
04/03/2014WO2014048404A1 A method of preparing a highly pure potassium salt of azilsartan medoxomil
04/03/2014WO2014048380A1 Preparation method of agomelatine solid preparation
04/03/2014WO2014048379A1 Drug composition for treating tumors and application thereof
04/03/2014WO2014048377A1 Drug composition for treating tumors and application thereof
04/03/2014WO2014048370A1 Compositions and methods of treating and preventing neuronal damage from traumatic brain injury
04/03/2014WO2014048355A1 Crystalline forms of dihydropyrimidine derivatives
04/03/2014WO2014048313A1 Condensation product of theanine derivative and carboxylic acid coumarin derivative, intermediate of the condensation product, method for preparing same, and use thereof
04/03/2014WO2014048243A1 Xanthine derivative, preparation method and use thereof
04/03/2014WO2014048165A1 Compound as potassium channel modulator
04/03/2014WO2014048109A1 Reagent for targeting degradation of bcr-abl protein and use in preparation of philadelphia chromosome-positive tumor-curing medicine
04/03/2014WO2014048072A1 Spiro ring compounds as hepatitis c virus (hcv) inhibitors
04/03/2014WO2014048071A1 Method and pharmaceutical composition for inhibiting pi3k/akt/mtor signal path
04/03/2014WO2014048070A1 Composition for promoting erythropoiesis and uses thereof
04/03/2014WO2014048065A1 Triazolyl derivatives as syk inhibitors
04/03/2014WO2014048033A1 Polymorphs of cddo ethyl ester and uses thereof
04/03/2014WO2014047996A1 New crystalline form of rosuvastatin methyl ester and preparation method thereof
04/03/2014WO2014047783A1 Pharmaceutical composition containing triptolide and triptolide derivative and bcl-2 inhibitor and use thereof
04/03/2014WO2014047782A1 Pharmaceutical composition containing resveratrol and resveratrol derivative and bcl-2 inhibitor and use thereof
04/03/2014WO2014047780A1 Pharmaceutical composition containing apigenin and apigenin derivative and oridonin and oridonin derivative and use thereof
04/03/2014WO2014047779A1 Pharmaceutical composition containing evodiamine and evodiamine derivative and bcl-2 inhibitor and use thereof
04/03/2014WO2014047731A1 Abuse deterrent pharmaceutical composition comprising konjac glucomannan
04/03/2014WO2014047722A1 Intranasal compositions for increasing cerbrospinal fluid clearance and devices, methods and uses thereof
04/03/2014WO2014047715A1 Treatment of pulmonary surfactant dysfunction using cholesterol-sequestering cyclodextrins
04/03/2014WO2014027981A3 Effervescent tablet formulations of dapoxetine and a pde5 inhibitor
04/03/2014WO2014025749A3 Small molecule inhibitors of viral protein interactions with human t-rna
04/03/2014WO2014025638A4 Pramipexole transdermal delivery for severe headaches
04/03/2014WO2014024077A9 5-(1H-PYRAZOL-4-YL)-1H-PYRROLO[2,3-b]PYRIDINE DERIVATIVES AS KINASE INHIBITORS
04/03/2014WO2014023867A3 Liposomes administered indepently from the active agents
04/03/2014WO2014022816A3 Pharmaceutical compositions comprising 15-hetre and methods of treating or preventing arthritis using same
04/03/2014WO2014015056A3 Anti-mucus drugs and uses therefor
04/03/2014WO2014013338A3 Compounds for the treatment of alzheimer's disease
04/03/2014WO2014013090A3 Formulation comprising amorphous fingolimod
04/03/2014WO2014004863A3 Compounds, compositions, and therapeutic uses thereof
04/03/2014WO2013192576A3 Oligonucleotide-based inhibitors comprising locked nucleic acid motif
04/03/2014WO2013187971A3 Macrocycles
04/03/2014WO2013185082A3 Inhibitors of bruton's tyrosine kinase
04/03/2014WO2013184037A3 Antibacterial pharmaceutical composition
04/03/2014WO2013180603A3 Method of production of biologically active complex-powder from the young shoots of sea buckthorn
04/03/2014WO2013167012A3 Synthesis method for l-heterocyclic amino acid and pharmaceutical composition having said acid
04/03/2014WO2013163244A8 Imidazothiadiazole derivatives as protease activated receptor 4 (par4) inhibitors for treating platelet aggregation
04/03/2014WO2013092457A3 Active agent combinations of one or more carboxylic acids, in particular hydroxycarboxylic acids, and of one or more physiologically harmless hydroxamic acids, and cosmetic or dermatological preparations containing such active agent combinations
04/03/2014WO2013092409A3 Active substance combinations of one or more aromatic alcohols and one or more physiologically acceptable hydroxamic acids, and cosmetic or dermatological preparations containing such active substance combinations
04/03/2014WO2013080140A3 Sunscreen compositions containing a novel preservative system
04/03/2014WO2013058758A3 Compounds, compositions, and methods for reducing or eliminating bitter taste
04/03/2014WO2013053983A8 Protein kinase inhibitors
04/03/2014WO2013040337A9 Phosphatidylinositol 3-kinase inhibitors for the treatment of cancer
04/03/2014WO2012083128A3 Prevention and treatment of diseases characterized by mesencephalic dopaminergic neuron cell death
04/03/2014WO2012078867A3 Cycloalkyl guanidine f1f0-atpase inhibitors and therapeutic uses thereof
04/03/2014WO2012075122A3 Processes and intermediates for preparing substituted hexahydrofuro [2,3-b] furans
04/03/2014WO2012074784A3 Novel fluorinated sulfamides exhibiting neuroprotective action and their method of use
04/03/2014WO2012068284A3 Efficient method for preparing functionalized benzosuberenes
04/03/2014WO2012068000A3 Methods of treating cancers with her3 and pik3ca antisense oligonucleotides
04/03/2014WO2012058463A3 Trimegestone (tmg) for treatment of preterm birth
04/03/2014WO2012054093A3 Acyl piperidine inhibitors of soluble epoxide hydrolase
04/03/2014WO2012048063A3 Cyanine compounds, conjugates and method of use
04/03/2014WO2012011939A3 Synthesis of cyclopentaquinazolines
04/03/2014WO2012009009A3 Novel 2-amino-4-pyrazolyl-thiazole derivatives and their use as allosteric modulators of metabotropic glutamate receptors
04/03/2014WO2011088418A3 Inhibition of tnf-alpha induced activation of nfkb by pentosan polysulfate
04/03/2014WO2010104790A3 Fatty-acid based particles
04/03/2014US20140094524 Astaxanthin-containing pet foods
04/03/2014US20140094523 Solid ambroxol-containing preparation
04/03/2014US20140094522 Compound formulations of 2-amino-1, 3-propanediol compounds
04/03/2014US20140094520 Omega-3 pentaenoic acid compositions and methods of use
1 ... 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 ... 7860